BD’s TriPath Imaging Buyout Would Integrate Cancer Diagnostics Partner

Becton Dickinson will gain TriPath Imaging's SurePath liquid-based Pap test and fledgling molecular oncology diagnostics business should its $350 mil. acquisition offer be accepted